Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Tonghua Technology Development is a specialized medical device company based in Wuhan, China, focusing on the field of cryomedicine. Established in 1994, the company is a leading developer and manufacturer of liquid nitrogen cryotherapy systems and cryosurgical instruments. Its product portfolio includes the YDZ and KCS series, which are widely utilized in clinical settings for dermatology, gynecology, and oncology to treat various benign and malignant lesions. The company integrates research, development, production, and sales, maintaining a significant presence in the domestic Chinese medical equipment market. Wuhan Tonghua is recognized as a high-tech enterprise and holds numerous patents related to cryogenic medical technology and its clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Tonghua Technology Development.